Harpoon Therapeutics Email Format

Pharmaceutical ManufacturingCalifornia, United States51-200 Employees

Harpoon Therapeutics is a clinical-stage biotechnology company focused on immuno-oncology. It develops a novel class of T cell engagers that recruit a patient’s own T cells to destroy cancer cells expressing specific antigens. The company relies on proprietary platforms to refine these therapies, including designs that limit activity until the product reaches the tumor and approaches intended to mitigate inflammatory side effects. Its pipeline targets solid tumors and hematologic malignancies, reflecting an aim to apply immune-based attack across cancer types.

The company is based in South San Francisco, California, and operates as a mid-sized biotechnology firm. In 2023, it reported updated interim tolerability and response data from a Phase 1/2 trial of its T cell engager in cancer.

Sign up for free to view info

Company overview Employee directory